ferroglycine sulfate
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Aug 23, 2017 (NCT03833336)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- IronSupplementation
Iron supplementation
Chemistry & pharmacology
- Mol. weight
- 226.97 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297671 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03833336 | Phase 3 | Aug 23, 2017 | Fundació La Marató de TV3, Institut de Recerca Biomèdica de Lleida |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fundació La Marató de TV3 | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Institut de Recerca Biomèdica de Lleida | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1